BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 30477496)

  • 1. An evaluation of TAZ and YAP crosstalk with TGFβ signalling in canine osteosarcoma suggests involvement of hippo signalling in disease progression.
    Luu AK; Schott CR; Jones R; Poon AC; Golding B; Hamed R; Deheshi B; Mutsaers A; Wood GA; Viloria-Petit AM
    BMC Vet Res; 2018 Nov; 14(1):365. PubMed ID: 30477496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crosstalk between Hippo and TGFβ: Subcellular Localization of YAP/TAZ/Smad Complexes.
    Grannas K; Arngården L; Lönn P; Mazurkiewicz M; Blokzijl A; Zieba A; Söderberg O
    J Mol Biol; 2015 Oct; 427(21):3407-15. PubMed ID: 25937570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.
    Rico C; Boerboom D; Paquet M
    Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary investigation of the role of the transcription co-activators YAP/TAZ of the Hippo signalling pathway in canine and feline mammary tumours.
    Beffagna G; Sacchetto R; Cavicchioli L; Sammarco A; Mainenti M; Ferro S; Trez D; Zulpo M; Michieletto S; Cecchinato A; Goldschmidt M; Zappulli V
    Vet J; 2016 Jan; 207():105-111. PubMed ID: 26626094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transcriptional regulators TAZ and YAP direct transforming growth factor β-induced tumorigenic phenotypes in breast cancer cells.
    Hiemer SE; Szymaniak AD; Varelas X
    J Biol Chem; 2014 May; 289(19):13461-74. PubMed ID: 24648515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating CXCR4 expression in canine appendicular osteosarcoma.
    Fan TM; Barger AM; Fredrickson RL; Fitzsimmons D; Garrett LD
    J Vet Intern Med; 2008; 22(3):602-8. PubMed ID: 18466248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
    Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
    BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hippo signaling pathway in companion animal diseases, an under investigated signaling cascade.
    Budel SJ; Penning MM; Penning LC
    Vet Q; 2021 Dec; 41(1):172-180. PubMed ID: 33945400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of the Hippo pathway transcriptional coactivators YAP/TAZ and β1-integrin in conventional osteosarcoma.
    Bouvier C; Macagno N; Nguyen Q; Loundou A; Jiguet-Jiglaire C; Gentet JC; Jouve JL; Rochwerger A; Mattei JC; Bouvard D; Salas S
    Oncotarget; 2016 Oct; 7(40):64702-64710. PubMed ID: 27608849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between absolute tumor burden and serum bone-specific alkaline phosphatase in canine appendicular osteosarcoma.
    Sternberg RA; Pondenis HC; Yang X; Mitchell MA; O'Brien RT; Garrett LD; Helferich WG; Hoffmann WE; Fan TM
    J Vet Intern Med; 2013; 27(4):955-63. PubMed ID: 23734720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins downregulate YAP and TAZ and exert anti-cancer effects in canine mammary tumour cells.
    Vigneau AL; Rico C; Boerboom D; Paquet M
    Vet Comp Oncol; 2022 Jun; 20(2):437-448. PubMed ID: 34881506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the Hippo/TAZ pathway is required for menstrual stem cells to suppress myofibroblast and inhibit transforming growth factor β signaling in human endometrial stromal cells.
    Zhu H; Pan Y; Jiang Y; Li J; Zhang Y; Zhang S
    Hum Reprod; 2019 Apr; 34(4):635-645. PubMed ID: 30715393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Verteporfin Inhibits the Progression of Spontaneous Osteosarcoma Caused by Trp53 and Rb1 Deficiency in Ctsk-Expressing Cells via Impeding Hippo Pathway.
    Li Y; Yang S; Yang S
    Cells; 2022 Apr; 11(8):. PubMed ID: 35456040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanically tunable coaxial electrospun models of YAP/TAZ mechanoresponse and IGF-1R activation in osteosarcoma.
    Molina ER; Chim LK; Salazar MC; Mehta SM; Menegaz BA; Lamhamedi-Cherradi SE; Satish T; Mohiuddin S; McCall D; Zaske AM; Cuglievan B; Lazar AJ; Scott DW; Grande-Allen JK; Ludwig JA; Mikos AG
    Acta Biomater; 2019 Dec; 100():38-51. PubMed ID: 31542501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hierarchy of TGFβ/SMAD, Hippo/YAP/TAZ, and Wnt/β-catenin signaling in melanoma phenotype switching.
    Lüönd F; Pirkl M; Hisano M; Prestigiacomo V; Kalathur RK; Beerenwinkel N; Christofori G
    Life Sci Alliance; 2022 Feb; 5(2):. PubMed ID: 34819356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hippo/YAP signaling pathway is involved in osteosarcoma chemoresistance.
    Wang DY; Wu YN; Huang JQ; Wang W; Xu M; Jia JP; Han G; Mao BB; Bi WZ
    Chin J Cancer; 2016 May; 35():47. PubMed ID: 27206784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating TrkA expression in canine appendicular osteosarcoma.
    Fan TM; Barger AM; Sprandel IT; Fredrickson RL
    J Vet Intern Med; 2008; 22(5):1181-8. PubMed ID: 18638015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of insulin-like growth factor-1 receptor is correlated with worse survival in canine appendicular osteosarcoma.
    Maniscalco L; Iussich S; Morello E; Martano M; Gattino F; Miretti S; Biolatti B; Accornero P; Martignani E; Sánchez-Céspedes R; Buracco P; De Maria R
    Vet J; 2015 Aug; 205(2):272-80. PubMed ID: 25257352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct polarity cues direct Taz/Yap and TGFβ receptor localization to differentially control TGFβ-induced Smad signaling.
    Narimatsu M; Samavarchi-Tehrani P; Varelas X; Wrana JL
    Dev Cell; 2015 Mar; 32(5):652-6. PubMed ID: 25758863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agave negatively regulates YAP and TAZ transcriptionally and post-translationally in osteosarcoma cell lines.
    Ferraiuolo M; Pulito C; Finch-Edmondson M; Korita E; Maidecchi A; Donzelli S; Muti P; Serra M; Sudol M; Strano S; Blandino G
    Cancer Lett; 2018 Oct; 433():18-32. PubMed ID: 29933048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.